Originally published by our sister publication Specialty Pharmacy Continuum
By Marcus A. Banks
Integrated delivery networks (IDNs) will be critical in improving access to cell and gene therapies in the coming years, with artificial intelligence and data-mining of electronic health records (EHRs) among the tools they will use to optimize outcomes, according to panelists at Asembia’s AXS25 Summit, in Las Vegas.